Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Clinical Study to Evaluate the Safety and Effect of RLS-1496 Topical Cream for the Treatment of Actinic Keratosis

NCT07340697 is registered in ClinicalTrials.gov with Rubedo Life Sciences, Inc. as lead sponsor.

NCT NCT07340697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07340697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Clinical Study to Evaluate the Safety and Effect of RLS-1496 Topical Cream for the Treatment of Actinic Keratosis
Lead sponsor
Rubedo Life Sciences, Inc.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
February 3, 2026
Completion date
August 31, 2026
Enrollment
24 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis (ak)